IL1B and Hyperglycemia: Meanwhile, silencing AQP4‐AS1 can downregulate the expression levels of VEGF, IL‐6, IL‐1β, and Intercellular Adhesion Molecule‐1, and reduce hyperglycemia‐induced retinal inflammasome [39].